GLMD   $3.79  9.54% Market Closed After Close 3.9 2.90%

Galmed Pharmaceuticals Ltd
Total Cash 9.82M
totalCashPerShare 18.538
EBITDA -6.14M
Total Debt 0.00
quickRatio 6.408
currentRatio 6.484
Total Revenue
debtToEquity
Revenue/Share
ROA -0.29313
ROE -0.52666
grossProfits
freeCashflow -4.07M
operatingCashflow -5.92M
earningsGrowth
revenueGrowth
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins 0.0
profitMargins 0.0
enterpriseValue -7.75M
forwardPE
floatShares 513.95K
sharesOutstanding 1.51M
sharesShort 34.16K
sharesShortPriorMonth 40.64K
dateShortInterest
sharesPercentSharesOut 0.02%
heldPercentInsiders 0.01%
heldPercentInstitutions 0.02%
Short Ratio help_outline 0.0
shortPercentOfFloat 0.02%
impliedSharesOutstanding
bookValue 22.244
Price To Book help_outline 0.18
earningsQuarterlyGrowth
netIncomeToCommon -5.88M
trailingEps -10.44%
forwardEps -1.03%
enterpriseToEbitda 1.26
lastDividendValue
lastDividendDate
currentQuarterEstimate 1Q 2024
institutionsCount 14
lastUpdated Oct. 16, 2024, 12:25 p.m.